参考文献/References:
［1］谢幸，苟文丽．妇产科学 ［M］．第8版．北京：人民卫生出版社，2013．
［2］Linnemann B,Bauersachs R,Rott H,et al. Treatment of pregnancy-associated venous thromboembolism – position paper of the Working Group in Women’s Health of the Society of Thrombosis and Haemostasis (GTH) ［J］ .Vasa，2016，45 (2): 103-118.
［3］American College of Obstetricians and Gynecologists Women's Health Care Physicians. ACOG Practice Bulletin No.138:Inherited thrombophilias in pregnancy ［J］.Obstet Gynecol，2013，122 (3):706-717.
［4］HEIT J A, KOBBERVIG C E, JAMES A H, et al. Trends in the incidence of venous thromboembolism during pregnancy or postpartum: a 30-year population-based study ［J］. Annals of Internal Medicine, 2005, 143 (10): 697-706.
［5］SULTAN A A, WEST J, TATA L J, et al. Risk of first venous thromboembolism in and around pregnancy: a population-based cohort study ［J］. British Journal of Haematology, 2012, 156 (3): 366-373.
［6］Regitz-Zagrosek V,Blomstrom Lundqvist C，Borghi C，et al.ESC Guidelines on the management of cardiovascular diseases during pregnancy: the Task Force on the Management of Cardiovascular Diseases during Pregnancy of the European Society of Cardiology (ESC) ［J］.Eur Heart J，2011，32 (24):3147-3197.
［7］VIRKUS R A, Lkkegaard EC, Bergholt T,et al.Venous thromboem-bolism in pregnant and puerperal women in Denmark 1995-2005. A national cohort study ［J］. Thrombosis & Haemostasis，2011,105(02):304-309.
［8］NELSON-PIERCY C, MACCALLUM P, MACKILLOP L. Reducing the risk of venous thromboembolism during pregnancy and the puerperium ［Z］. 3rd ed, 2015.
［9］Bourjeily G, Paidas M, Khalil H, et al. Pulmonary embolism in pregnancy ［J］. Lancet，2010，375: 500–512.
［10］JAMES A H, JAMISON M G, BRANCAZIO L R, et al. Venous thromboembolism during pregnancy and the postpartum period: Incidence, risk factors, and mortality ［J］. American Journal of Obstetrics and Gynecology, 2006, 194 (5): 1311-1315.
［11］MCCOLL M D, WALKER I D, GREER I A. The role of inherited thrombophilia in venous thromboembolism associated with pregnancy ［J］. British Journal of Obstetrics and Gynaecology, 1999, 106 (8): 756-766.
［12］Gerhardt A, Scharf RE, Zotz RB. Effect of hemostatic risk factors on the individual probability of thrombosis during pregnancy and the puerperium ［J］. Thromb Haemost，2003,90 (1):77–85.
［13］Scifres CM, Macones GA. The utility of thrombophilia testing in pregnant women with thrombosis: fact or fiction? ［J］. Am J Obstet Gynecol，2008，199 (4):344.e1–344.e7.
［14］VERNINI J M, MORELI J B, MAGALHES C G, et al. Maternal and fetal outcomes in pregnancies complicated by overweight and obesity ［J］. Reproductive Health, 2016, 13 (1): 100.
［15］JACOBSEN A F, SKJELDESTAD F E, SANDSET P M. Incidence and risk patterns of venous thromboembolism in pregnancy and puerperium--a register-based case-control study ［J］. American Journal of Obstetrics and Gynecology, 2008, 198 (2): 233.e1-233.e7.
［16］NELSON S M. Prophylaxis of VTE in women–during assisted reproductive techniques ［Z］, 2009: S8–S15.
［17］中华医学会妇产科学分会产科学组．复发性流产诊治的专家共识 ［J］．中华妇产科杂志，2016，51（1）：3-9．
［18］段涛．重视妊娠期抗凝药物的合理应用 ［J］．中国实用妇科与产科杂志，2017，33（7）：665-666．
［19］Lindqvist PG, Bremme K, Hellgren M; Swedish Society of Obstetrics and Gynecology (SFOG) Working Group onHemostatic Disorders (Hem-ARG). Efficacy of obstetric thromboprophylaxis and long-term risk of recurrence of venous thromboembolism ［J］. Acta Obstet Gynecol Scand 2011，90：648 –653.
［20］NISHIMURA R A, OTTO C M, BONOW R O, et al. 2014 AHA/ACC guideline for the management of patients with valvular heart disease：a report of the American college of cardiology/American heart association task force on practice guidelines ［J］. Circulation, 2014, 63 (22): 2438-2488.
［21］中华医学会风湿病学分会．抗磷脂综合征诊断和治疗指南 ［J］．中华风湿病学杂志，2011，15（6）：407-410．
［22］LI C, RAIKWAR N S, SANTILLAN M K, et al. Aspirin inhibits expression of sFLT1 from human cytotrophoblasts induced by hypoxia,via cyclo-oxygenase 1 ［J］. Placenta, 2015, 36 (4): 446-453.
［23］中华医学会妇产科学分会妊娠期高血压疾病学组．妊娠期高血压疾病诊治指南(2015) ［J］．中华妇产科杂志，2015，50（10）：721-728．
［24］Bates SM, Greer IA, Middeldorp S, et al. VTE, thrombophilia, antithrombotic therapy, and pregnancy: Antithrombotic Therapy and Prevention of Thrombosis, 9 ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. American College of Chest Physicians ［J］. Chest 2012，141(suppl).
［25］KNOL H M, SCHULTINGE L, VEEGER N J, et al. The risk of postpartum hemorrhage in women using high dose of low-molecular-weight heparins during pregnancy ［J］. Thrombosis Research, 2012, 130 (3): 334-338.
［26］GREER I A, CATHERINE N P. Low-molecular-weight heparins for thrombo prophylaxis and treatment of venous thrombo embolism in pregnancy:a systematic review of safety and defficacy ［J］. Blood, 2005, 106(2): 401-407.
相似文献/References:
[1]吴池华,刘锦平.妊娠哺乳期乳腺癌的临床问题[J].中国计划生育和妇产科,2009,(05):0.
WU Chi-hua,LIU Jin-ping The department of breast surgery,The academy of science · Sichuan provincal peoples hospital.[J].Chinese Journal of Family Planning & Gynecotokology,2009,(10):0.
[2]夏晓梦,方小玲.妊娠期宫颈细胞学与阴道镜检查的特征与处理[J].中国计划生育和妇产科,2013,(01):0.
XIA Xiao-meng,FANG Xiao-ling*.[J].Chinese Journal of Family Planning & Gynecotokology,2013,(10):0.
[3]李光辉,孔丽君,张为远,等.子痫前期的脂代谢[J].中国计划生育和妇产科,2014,(01):0.
LI Guang-hui,KONG Li-jun,ZHANG Wei-yuan,et al.[J].Chinese Journal of Family Planning & Gynecotokology,2014,(10):0.
[4]陈彧,冯欣,杨华,等.妊娠期疾病常用中成药使用原则及禁忌[J].中国计划生育和妇产科,2015,(02):0.
[5]周慧梅,李威,朱兰,等.妊娠期急性阑尾炎诊治进展[J].中国计划生育和妇产科,2015,(02):0.
[6]崔淑娟,马艳芬.妊娠期心理压力与自然流产的关系[J].中国计划生育和妇产科,2015,(03):0.
CUI Shu-juan,MA Yan-fen,[J].Chinese Journal of Family Planning & Gynecotokology,2015,(10):0.
[7]何书励,马良坤,刘俊涛,等.早产和营养[J].中国计划生育和妇产科,2015,(05):0.
[8]杨孜,张为远.如何理解和践行中国妊娠期高血压疾病诊治指南(2015)[J].中国计划生育和妇产科,2016,(04):0.
[9]李力,顾焱,陈建坤,等.妊娠期高血压疾病与产后出血[J].中国计划生育和妇产科,2016,(04):0.
[10]付婷,侯顺玉.妊娠期暴发性1型糖尿病发生死胎1例及相关文献复习[J].中国计划生育和妇产科,2016,(06):0.